These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12436918)

  • 1. Development of vasculature targeting strategies for the treatment of cancer and chronic inflammatory diseases.
    Schraa AJ; Everts M; Kok RJ; Asgeirsdóttir SA; Meijer DK; de Leij LF; Molema G
    Biotechnol Annu Rev; 2002; 8():133-65. PubMed ID: 12436918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of vascular endothelium-specific drug-targeting strategies for the treatment of cancer.
    Molema G
    Acta Biochim Pol; 2005; 52(2):301-10. PubMed ID: 15990916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cells at inflammatory sites as target for therapeutic intervention.
    Koning GA; Schiffelers RM; Storm G
    Endothelium; 2002; 9(3):161-71. PubMed ID: 12380641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New strategies in anti-vascular cancer therapy.
    Bloemendal HJ; Logtenberg T; Voest EE
    Eur J Clin Invest; 1999 Sep; 29(9):802-9. PubMed ID: 10469169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The critical role of vascular endothelial growth factor in tumor angiogenesis.
    Amini A; Masoumi Moghaddam S; Morris DL; Pourgholami MH
    Curr Cancer Drug Targets; 2012 Jan; 12(1):23-43. PubMed ID: 22111836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and validation of drug targets for tumour angiogenesis.
    Kremmidiotis G; Lavranos TC
    Expert Opin Ther Targets; 2005 Apr; 9(2):211-5. PubMed ID: 15934910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor vasculature targeted therapies: getting the players organized.
    Molema G; Meijer DK; de Leij LF
    Biochem Pharmacol; 1998 Jun; 55(12):1939-45. PubMed ID: 9714313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective induction of tumor ischemia: development of vascular targeting agents for cancer therapy.
    Chaplin DJ; Hill SA
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1381-4. PubMed ID: 12498016
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor vascular endothelium: barrier or target in tumor directed drug delivery and immunotherapy.
    Molema G; de Leij LF; Meijer DK
    Pharm Res; 1997 Jan; 14(1):2-10. PubMed ID: 9034214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination drug delivery via multilamellar vesicles enables targeting of tumor cells and tumor vasculature.
    Liu Y; Kim YJ; Siriwon N; Rohrs JA; Yu Z; Wanga P
    Biotechnol Bioeng; 2018 Jun; 115(6):1403-1415. PubMed ID: 29457630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in tumor vasculature targeting using liposomal drug delivery systems.
    Abu Lila AS; Ishida T; Kiwada H
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1297-309. PubMed ID: 19780711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Inflammatory Vasculature by Extracellular Vesicles.
    Wang S; Dong X; Gao J; Wang Z
    AAPS J; 2018 Feb; 20(2):37. PubMed ID: 29484558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor vasculature directed drug targeting: applying new technologies and knowledge to the development of clinically relevant therapies.
    Molema G
    Pharm Res; 2002 Sep; 19(9):1251-8. PubMed ID: 12403059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cells as therapeutic targets in cancer: new biology and novel delivery systems.
    Murray JC; Moghimi SM
    Crit Rev Ther Drug Carrier Syst; 2003; 20(2-3):139-52. PubMed ID: 14584522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of vascular-targeting drugs in a computational model of tumor growth.
    Gevertz J
    Phys Rev E Stat Nonlin Soft Matter Phys; 2012 Apr; 85(4 Pt 1):041914. PubMed ID: 22680505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the tumor vascular compartment to improve conventional cancer therapy.
    Feron O
    Trends Pharmacol Sci; 2004 Oct; 25(10):536-42. PubMed ID: 15380938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnological and biotechnological strategies for drug delivery.
    Galdiero M; Caraglia M
    Curr Drug Metab; 2012 Jan; 13(1):2-3. PubMed ID: 22385533
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumour and dendrimers: a review on drug delivery aspects.
    Agarwal A; Asthana A; Gupta U; Jain NK
    J Pharm Pharmacol; 2008 Jun; 60(6):671-88. PubMed ID: 18498702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [VEGF, anti-vEGF and diseases].
    Corvol P
    Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of tumor endothelial cells and drug delivery.
    Hida K; Maishi N; Sakurai Y; Hida Y; Harashima H
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):140-147. PubMed ID: 26626622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.